These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33919076)

  • 1. Coxsackievirus B3-Its Potential as an Oncolytic Virus.
    Geisler A; Hazini A; Heimann L; Kurreck J; Fechner H
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
    Hazini A; Pryshliak M; Brückner V; Klingel K; Sauter M; Pinkert S; Kurreck J; Fechner H
    Hum Gene Ther; 2018 Nov; 29(11):1301-1314. PubMed ID: 29739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.
    Lin Y; Liu N; Yang C; Tan H; Fang C; Yu K; Zhao H; Xia N; Wang W; Huang X; Cheng T
    Virol J; 2024 Oct; 21(1):245. PubMed ID: 39369233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
    Sagara M; Miyamoto S; Itoh S; Soda Y; Tani K
    Anticancer Res; 2021 Jan; 41(1):81-89. PubMed ID: 33419801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
    Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
    Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
    Miyamoto S; Inoue H; Nakamura T; Yamada M; Sakamoto C; Urata Y; Okazaki T; Marumoto T; Takahashi A; Takayama K; Nakanishi Y; Shimizu H; Tani K
    Cancer Res; 2012 May; 72(10):2609-21. PubMed ID: 22461509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncolytic coxsackievirus therapy as an immunostimulator].
    Miyamoto S; Sagara M; Kohara H; Tani K
    Rinsho Ketsueki; 2017; 58(8):977-982. PubMed ID: 28883283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320.
    Girod M; Geisler A; Hinze L; Elsner L; Dieringer B; Beling A; Kurreck J; Fechner H
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H.
    Hazini A; Dieringer B; Klingel K; Pryshliak M; Geisler A; Kobelt D; Daberkow O; Kurreck J; Linthout SV; Fechner H
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a microRNA-Regulated Oncolytic Coxsackievirus B3.
    Dieringer B; Elsner L; Hazini A; Kurreck J; Fechner H
    Methods Mol Biol; 2022; 2521():259-282. PubMed ID: 35733003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.
    Liu H; Luo H
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy.
    Elsner L; Heimann L; Geisler A; Dieringer B; Knoch KP; Hinze L; Klingel K; Solimena M; Kurreck J; Fechner H
    Biol Proced Online; 2024 Apr; 26(1):11. PubMed ID: 38664647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy.
    Hensen LCM; Hoeben RC; Bots STF
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.
    Takagi-Kimura M; Yamano T; Tagawa M; Kubo S
    Cancer Gene Ther; 2014 Mar; 21(3):126-32. PubMed ID: 24577130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth.
    Yoon AR; Hong J; Yun CO
    Oncotarget; 2015 Oct; 6(33):34875-91. PubMed ID: 26430798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy.
    Bahreyni A; Liu H; Mohamud Y; Xue YC; Fan YM; Zhang YL; Luo H
    BMC Med; 2023 May; 21(1):193. PubMed ID: 37226233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells.
    Pryshliak M; Hazini A; Knoch K; Dieringer B; Tolksdorf B; Solimena M; Kurreck J; Pinkert S; Fechner H
    FEBS Lett; 2020 Feb; 594(4):763-775. PubMed ID: 31643074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3.
    Liu H; Bahreyni A; Mohamud Y; Xue YC; Jia WWG; Luo H
    Mol Ther Oncolytics; 2022 Dec; 27():89-99. PubMed ID: 36321136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice.
    Bahreyni A; Liu H; Mohamud Y; Xue YC; Zhang J; Luo H
    Cancer Lett; 2022 Nov; 548():215849. PubMed ID: 35995138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.
    Sam M; Selman M; Zhao W; Jung J; Willingham A; Phan U; Starling GC; Gao Q
    J Virol; 2023 May; 97(5):e0030923. PubMed ID: 37070982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.